GRAL GRAIL, Inc. - Common Stock

NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗
$75,83
Prezzo · Ago 19, 2026
Fondamentali al Ago 6, 2026

Informazioni su GRAIL, Inc. - Common Stock Panoramica della società da Wikipedia

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

Leggi di più

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.

Activities

Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.

Galleri test

As of November 2020 Galleri investigated three multi-cancer screening tests.

In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.

In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.

On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.

Company history

Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.

In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.

On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.

In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.

In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.

In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

GRAL Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo
$75.83
Capitalizzazione di Mercato
$3.12T
P/E (TTM)
-6961.3
EPS (TTM)
$-11.11
Ricavi (TTM)
$147M
Rendimento div.
ROE
-16.7%
D/E Debito/Patrimonio
Intervallo 52 sett.
$30 – $119

GRAL Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $147M
4-point trend, +164.9%
2023-01-01 2025-12-31
EPS $-11.11
4-point trend, +93.6%
2023-01-01 2025-12-31
Flusso di cassa libero $-300M
2-point trend, +48.5%
2024-12-31 2025-12-31
Margini -277.5%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer
P/E (TTM)
2-point trend, -2642.6%
-6961.3
P/S (TTM)
2-point trend, +386.9%
21194.3
18.3
P/B
2-point trend, +454.0%
1210.0
3.3
Price / FCF (Prezzo / FCF)
2-point trend, -1007.9%
-10400.3

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer
Operating Margin (Margine Operativo)
2-point trend, +78.1%
-382.0%
Net Profit Margin (Margine di Profitto Netto)
2-point trend, +82.8%
-277.5%
-180.4%
ROA
2-point trend, +76.5%
-13.8%
-36.2%
ROE
2-point trend, +79.0%
-16.7%
-43.7%
ROIC
2-point trend, +79.7%
-16.7%

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer
Current Ratio (Rapporto corrente)
2-point trend, +12.3%
12.0
9.7
Quick Ratio
2-point trend, +10.3%
3.4

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer
Revenue YoY (Ricavi YoY)
4-point trend, +164.9%
17.2%
Revenue CAGR 3Y (CAGR Ricavi 3Y)
4-point trend, +164.9%
38.4%

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer
EPS (Diluted) (EPS (Diluito))
4-point trend, +93.6%
$-11.11

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica
Tendenza 5 anni
GRAL
Mediana dei peer

GRAL Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 15 analisti
  • Acquisto forte 4 26,7%
  • Compra 5 33,3%
  • Mantieni 6 40,0%
  • Vendi 0 0,0%
  • Vendita forte 0 0,0%

Target Price a 12 Mesi

8 analisti · 2026-08-19
Target mediano $74.50 -1,8%
Target medio $72.38 -4,6%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media
0.61%
Periodo EPS Actual EPS Stimato Sorpresa
30 Giugno 2026 $-2.56 $-2.71 0.15%
31 Marzo 2026 $-2.29 $-2.82 0.53%
31 Dicembre 2025 $-2.44 $-2.76 0.32%
30 Settembre 2025 $-2.46 $-3.59 1.1%
30 Giugno 2025 $-3.18 $-3.64 0.46%
31 Marzo 2025 $-3.10 $-4.17 1.1%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker Capitalizzazione di Mercato P/E Rev YoY Margine Netto ROE Margine lordo
GRAL $3.45B -7.7 17.2% -277.5% -16.7%
RCUS $2.99B -7.2 -4.3% -142.9% -59.8%
VCYT $3.34B 51.3 16.0% 12.8% 5.2% 70.1%
IDYA $3.04B -27.0 3024.4% -52.0% -11.5%
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8%
ARQT $3.58B -223.4 91.3% -4.3% -9.8%
IOVA $1.12B -2.5 60.6% -148.4% -56.0%
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0%
IRON $3.01B -13.2 -31.3%
NRIX $1.80B -5.8 53.9% -314.9% -53.6%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15
Dati annuali Conto Economico per GRAL
Metrica Tendenza 202520242023
Revenue 3-point trend, +58.1% $147M $126M $93M
R&D Expense 3-point trend, -42.2% $196M $322M $339M
SG&A Expense 3-point trend, -20.6% $159M $214M $200M
Operating Expenses 3-point trend, -55.9% $709M $2.31B $1.61B
Operating Income 3-point trend, +62.9% $-562M $-2.19B $-1.52B
Interest Income 3-point trend, +260.2% $29M $27M $8M
Other Non-op 3-point trend, -377.4% $-993.0K $64.0K $-208.0K
Pretax Income 3-point trend, +64.5% $-535M $-2.16B $-1.51B
Income Tax 3-point trend, -200.7% $-126M $-135M $-42M
Net Income 3-point trend, +72.1% $-408M $-2.03B $-1.47B
EPS (Basic) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
EPS (Diluted) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
Shares (Basic) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
Shares (Diluted) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
EBITDA 2-point trend, +74.3% $-562M $-2.19B ·
Stato Patrimoniale 25
Dati annuali Stato Patrimoniale per GRAL
Metrica Tendenza 202520242023
Cash & Equivalents 3-point trend, +156.7% $250M $214M $97M
Receivables 3-point trend, +8.0% $18M $20M $17M
Prepaid Expense 3-point trend, -25.0% $15M $17M $20M
Current Assets 3-point trend, +511.2% $954M $820M $156M
PP&E (Net) 3-point trend, -39.0% $52M $69M $85M
PP&E (Gross) 3-point trend, +1.4% $122M $123M $121M
Accum. Depreciation 3-point trend, +98.2% $70M $54M $36M
Goodwill 2-point trend, -100.0% · $0 $889M
Intangibles 3-point trend, -31.1% $1.85B $2.02B $2.69B
Other Non-current Assets 3-point trend, -15.4% $7M $8M $8M
Total Assets 3-point trend, -25.3% $2.92B $2.98B $3.91B
Accounts Payable 3-point trend, -89.4% $2M $5M $20M
Accrued Liabilities 3-point trend, -13.4% $64M $57M $74M
Current Liabilities 3-point trend, -51.3% $80M $77M $164M
Capital Leases 3-point trend, -38.0% $43M $55M $70M
Deferred Tax 3-point trend, +564.0% $219M $346M $33M
Other Non-current Liabilities 3-point trend, +83.7% $3M $2M $1M
Total Liabilities 3-point trend, +28.6% $344M $480M $268M
Common Stock 2-point trend, +17.6% $40.0K $34.0K ·
Paid-in Capital 2-point trend, +3.9% $12.79B $12.31B ·
Retained Earnings 3-point trend, -31.3% $-10.21B $-9.80B $-7.78B
AOCI 3-point trend, +149.1% $3M $1M $1M
Stockholders' Equity 2-point trend, +3.0% $2.58B $2.50B ·
Liabilities + Equity 3-point trend, -25.3% $2.92B $2.98B $3.91B
Shares Outstanding 3-point trend, +40331360.00 40,331,360 33,893,409,000 0
Flusso di cassa 10
Dati annuali Flusso di cassa per GRAL
Metrica Tendenza 202520242023
Stock-based Comp 3-point trend, -40.1% $58M $86M $97M
Deferred Tax 3-point trend, -230.7% $-126M $-134M $-38M
Amort. of Intangibles Flat — no change across 3 periods $134M $134M $134M
Operating Cash Flow 3-point trend, +49.8% $-299M $-577M $-596M
CapEx 3-point trend, -92.9% $909.0K $5M $13M
Investing Cash Flow 3-point trend, -560.0% $-85M $-551M $-13M
Financing Cash Flow 3-point trend, -8.7% $423M $1.24B $464M
Net Change in Cash 3-point trend, +127.0% $39M $116M $-145M
Taxes Paid $1M · ·
Free Cash Flow 2-point trend, +48.5% $-300M $-582M ·
Redditività 7
Dati annuali Redditività per GRAL
Metrica Tendenza 202520242023
Operating Margin 2-point trend, +78.1% -382.0% -1743.0% ·
Net Margin 2-point trend, +82.8% -277.5% -1613.9% ·
Pretax Margin 2-point trend, +78.9% -363.2% -1721.7% ·
EBITDA Margin 2-point trend, +78.1% -382.0% -1743.0% ·
ROA 2-point trend, +76.5% -13.8% -58.8% ·
ROE 2-point trend, +79.0% -16.7% -79.6% ·
ROIC 2-point trend, +79.7% -16.7% -82.0% ·
Liquidità e Solvibilità 2
Dati annuali Liquidità e Solvibilità per GRAL
Metrica Tendenza 202520242023
Current Ratio 2-point trend, +12.3% 12.0 10.7 ·
Quick Ratio 2-point trend, +10.3% 3.4 3.0 ·
Efficienza 2
Dati annuali Efficienza per GRAL
Metrica Tendenza 202520242023
Asset Turnover 2-point trend, +36.8% 0.0 0.0 ·
Receivables Turnover 2-point trend, +13.1% 7.6 6.7 ·
Per Azione 5
Dati annuali Per Azione per GRAL
Metrica Tendenza 202520242023
Book Value / Share 2-point trend, -13.5% $63.92 $73.86 ·
Revenue / Share 2-point trend, +1.7% $4.00 $3.94 ·
Cash Flow / Share 2-point trend, +55.0% $-8.14 $-18.09 ·
Cash / Share 2-point trend, -2.0% $6.19 $6.32 ·
EPS (TTM) 2-point trend, +82.5% $-11.11 $-63.54 ·
Tassi di Crescita 2
Dati annuali Tassi di Crescita per GRAL
Metrica Tendenza 202520242023
Revenue YoY 3-point trend, -74.6% 17.2% 34.9% 67.6%
Revenue CAGR 3Y 38.4% · ·
Valutazione (TTM) 10
Dati annuali Valutazione (TTM) per GRAL
Metrica Tendenza 202520242023
Revenue TTM 2-point trend, +17.2% $147M $126M ·
Net Income TTM 2-point trend, +79.9% $-408M $-2.03B ·
Market Cap 2-point trend, +470.6% $3.45B $605M ·
P/E 2-point trend, -2642.6% -7.7 -0.3 ·
P/S 2-point trend, +386.9% 23.5 4.8 ·
P/B 2-point trend, +454.0% 1.3 0.2 ·
P / Tangible Book 2-point trend, +281.7% 4.7 1.2 ·
P / Cash Flow 2-point trend, -1001.4% -11.5 -1.0 ·
P / FCF 2-point trend, -1007.9% -11.5 -1.0 ·
Earnings Yield 2-point trend, +96.4% -13.0% -356.0% ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico
2025-12-312024-12-312023-12-312023-01-01
Ricavi $147M$126M$93M$56M
Margine Operativo % -382.0%-1743.0%
Utile netto $-408M$-2.03B$-1.47B$-5.40B
EPS Diluito $-11.11$-63.54$-47.21$-173.89
Stato Patrimoniale
2025-12-312024-12-312023-12-312023-01-01
Rapporto corrente 12.010.7
Quick Ratio 3.43.0
Flusso di cassa
2025-12-312024-12-312023-12-312023-01-01
Flusso di cassa libero $-300M$-582M

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 411 filer · $2.2B totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente
Nuove posizioni Posizioni chiuse Aumentato Diminuito Variazione netta delle azioni
67 (+16 vs trimestre precedente) 45 (-49 vs trimestre precedente) 106 (+8 vs trimestre precedente) 102 (-12 vs trimestre precedente) +6.7M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione Valore Azioni % di 13F tracciati Tipo
FARALLON CAPITAL MANAGEMENT, L.L.C. $284.111.340 4.161.584 13,20% Azioni
BAKER BROS. ADVISORS LP $275.033.478 4.028.614 12,78% Azioni
STATE STREET CORP $162.859.041 2.385.514 7,57% Azioni
PRIMECAP MANAGEMENT CO/CA/ $148.835.838 2.180.106 6,91% Azioni
Sessa Capital IM, L.P. $139.101.354 2.037.518 6,46% Azioni
Deep Track Capital, LP $125.271.627 1.834.944 5,82% Azioni
VANGUARD CAPITAL MANAGEMENT LLC $112.039.058 1.641.117 5,21% Azioni
Arbiter Partners Capital Management LLC $70.611.456 1.034.297 3,28% Azioni
GEODE CAPITAL MANAGEMENT, LLC $58.460.697 856.182 2,72% Azioni
Jefferies Financial Group Inc. $49.427.480 724.000 2,30% Azioni
Jefferies Financial Group Inc. $44.375.500 650.000 2,06% Opzione Put
DIMENSIONAL FUND ADVISORS LP $43.707.751 640.219 2,03% Azioni
GOLDMAN SACHS GROUP INC $42.579.111 623.687 1,98% Azioni
BANK OF AMERICA CORP /DE/ $42.152.219 617.434 1,96% Azioni
Casdin Capital, LLC $32.769.600 480.000 1,52% Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC $32.631.831 477.982 1,52% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $25.396.440 372.000 1,18% Opzione Call
SUSQUEHANNA INTERNATIONAL GROUP, LLP $24.563.546 359.800 1,14% Opzione Put
KINGDON CAPITAL MANAGEMENT, L.L.C. $23.211.800 340.000 1,08% Azioni
Granahan Investment Management, LLC $21.926.686 321.176 1,02% Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $20.523.874 300.628 0,95% Azioni
Aberdeen Group plc $15.668.170 229.503 0,73% Azioni
VANGUARD FIDUCIARY TRUST CO $15.357.337 224.950 0,71% Azioni
Slow Capital, Inc. $14.832.477 217.262 0,69% Azioni
CITADEL ADVISORS LLC $14.616.607 214.100 0,68% Opzione Call
TCW GROUP INC $13.101.901 191.913 0,61% Azioni
Douglas Lane & Associates, LLC $11.082.952 162.340 0,51% Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP $10.601.990 155.295 0,49% Azioni
RAYMOND JAMES FINANCIAL INC $10.495.215 153.731 0,49% Azioni
Newtyn Management, LLC $10.240.500 150.000 0,48% Azioni
180 WEALTH ADVISORS, LLC $8.723.113 127.774 0,41% Azioni
Voleon Capital Management LP $8.264.903 121.062 0,38% Azioni
FMR LLC $8.139.559 119.226 0,38% Azioni
WIM INVESTMENT MANAGEMENT Ltd $7.263.928 106.400 0,34% Azioni
Alyeska Investment Group, L.P. $7.168.350 105.000 0,33% Azioni
AMERICAN CENTURY COMPANIES INC $6.774.228 99.227 0,31% Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $5.809.000 85.089 0,27% Azioni
Swiss National Bank $5.202.174 76.200 0,24% Azioni
Susquehanna Portfolio Strategies, LLC $4.853.178 71.088 0,23% Azioni
NATIXIS $4.794.329 70.226 0,22% Azioni
CITADEL ADVISORS LLC $4.601.398 67.400 0,21% Opzione Put
BARCLAYS PLC $4.557.091 66.751 0,21% Azioni
GAMCO INVESTORS, INC. ET AL $4.554.497 66.713 0,21% Azioni
D. E. Shaw & Co., Inc. $4.444.787 65.106 0,21% Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC $3.810.968 55.822 0,18% Azioni
Allianz Asset Management GmbH $3.810.695 55.818 0,18% Azioni
JANE STREET GROUP, LLC $3.775.331 55.300 0,18% Opzione Call
RHUMBLINE ADVISERS $3.773.202 55.269 0,18% Azioni
Public Sector Pension Investment Board $3.633.534 53.223 0,17% Azioni
Pictet Asset Management Holding SA $3.421.492 50.039 0,16% Azioni
Centiva Capital, LP $3.413.500 50.000 0,16% Opzione Call
Verition Fund Management LLC $3.334.921 48.849 0,15% Azioni
BlackRock, Inc. $3.131.886 45.875 0,15% Azioni
BNP PARIBAS FINANCIAL MARKETS $3.072.150 450 0,14% Opzione Call
D. E. Shaw & Co., Inc. $3.072.150 45.000 0,14% Opzione Put
Legal Advantage Investments, Inc. $3.046.549 44.625 0,14% Azioni
HighTower Advisors, LLC $2.769.342 40.565 0,13% Azioni
Rafferty Asset Management, LLC $2.697.962 39.519 0,13% Azioni
Timelo Investment Management Inc. $2.662.530 39.000 0,12% Azioni
ALLIANCEBERNSTEIN L.P. $2.492.320 48.226 0,12% Azioni
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $2.298.210 44.470 0,11% Azioni
Lido Advisors, LLC $2.270.250 33.254 0,11% Azioni
BNP PARIBAS FINANCIAL MARKETS $2.252.910 330 0,10% Opzione Put
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $2.211.768 30.719 0,10% Azioni
BNP PARIBAS FINANCIAL MARKETS $2.133.984 31.258 0,10% Azioni
Summit Financial, LLC $2.103.877 30.817 0,10% Azioni
GABELLI FUNDS LLC $2.067.420 30.283 0,10% Azioni
JONES FINANCIAL COMPANIES LLLP $1.988.740 30.169 0,09% Azioni
OSAIC HOLDINGS, INC. $1.906.981 27.934 0,09% Azioni
TWO SIGMA INVESTMENTS, LP $1.872.305 27.425 0,09% Azioni
COMMERCE BANK $1.841.993 26.981 0,09% Azioni
UBS Group AG $1.835.234 26.882 0,09% Azioni
Concurrent Investment Advisors, LLC $1.833.850 26.862 0,09% Azioni
Gem Investment Advisors, LLC $1.828.339 26.781 0,08% Azioni
VANGUARD ASSET MANAGEMENT, Ltd $1.823.765 26.714 0,08% Azioni
Legato Capital Management LLC $1.804.649 26.434 0,08% Azioni
PVG ASSET MANAGEMENT CORP $1.767.305 25.887 0,08% Azioni
CANADA PENSION PLAN INVESTMENT BOARD $1.761.366 25.800 0,08% Azioni
IMC-Chicago, LLC $1.710.368 25.053 0,08% Azioni
Jackson Hole Capital Partners, LLC $1.705.440 33.000 0,08% Azioni
Sheets Smith Investment Management $1.688.635 28.558 0,08% Azioni
MetLife Investment Management, LLC $1.649.813 24.166 0,08% Azioni
Gotham Asset Management, LLC $1.634.384 23.940 0,08% Azioni
Quantinno Capital Management LP $1.593.922 23.347 0,07% Azioni
TWO SIGMA ADVISERS, LP $1.592.060 18.601 0,07% Azioni
CLOUGH CAPITAL PARTNERS L P $1.566.387 22.944 0,07% Azioni
STATE OF WISCONSIN INVESTMENT BOARD $1.522.353 22.299 0,07% Azioni
MANUFACTURERS LIFE INSURANCE COMPANY, THE $1.474.427 21.597 0,07% Azioni
LPL Financial LLC $1.393.254 20.408 0,06% Azioni
PROFUND ADVISORS LLC $1.370.725 20.078 0,06% Azioni
Perigon Wealth Management, LLC $1.348.537 19.753 0,06% Azioni
Zurcher Kantonalbank (Zurich Cantonalbank) $1.271.324 18.622 0,06% Azioni
Invesco Ltd. $1.117.853 16.374 0,05% Azioni
Bouvel Investment Partners, LLC $1.106.998 16.215 0,05% Azioni
AMERIPRISE FINANCIAL INC $1.082.216 15.852 0,05% Azioni
NORGES BANK $1.077.983 15.790 0,05% Azioni
EXCHANGE TRADED CONCEPTS, LLC $1.054.703 15.449 0,05% Azioni
STRS OHIO $1.044.531 15.300 0,05% Azioni
PRUDENTIAL FINANCIAL INC $1.006.300 14.740 0,05% Azioni
NEW YORK STATE COMMON RETIREMENT FUND $996.469 14.596 0,05% Azioni

Insider aziendali 8 insider · 2 dirigenti · 5 direttori

Insider Ruolo Ultima attività Azioni possedute Acquisti 12m Vendite 12m Netto 12m
Joshua J. Ofman Chief Executive Officer 01 Giugno 2026 A 402.271 0 0 $0
Andrew John Partridge Chief Growth Officer 04 Giugno 2026 S 163.738 0 1 $-91.070
William J Chase Direttore 15 Luglio 2026 A 42.978 0 0 $0
Steven Mizell Direttore 15 Luglio 2026 A 42.830 0 0 $0
Gregory L Summe Direttore 15 Luglio 2026 A 45.672 0 0 $0
Sarah Krevans Direttore 18 Giugno 2026 A 42.628 0 0 $0
ILLUMINA, INC. Proprietario del 10% 17 Novembre 2025 S 3.502.126 0 1 $-79.850.000
Chun R Ding Proprietario del 10% 09 Ottobre 2024 P 3.644.855 0 0 $0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 50 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo Peso Unità Aggiornato al Fonte
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,90% 18.597 NS 30 Aprile 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,63% 59.651 NS 30 Aprile 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,21% 87.481 SH 08 Agosto 2026 Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust … 0,20% 2.336 SH 08 Agosto 2026 Giornaliero
IBB · iShares Trust 0,19% 291.644 SH 08 Agosto 2026 Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS 0,18% 36.116 SH 08 Agosto 2026 Giornaliero
AVSC · AMERICAN CENTURY ETF TRUST 0,17% 67.501 NS 31 Maggio 2026 N-PORT
IWN · iShares Trust 0,17% 385.837 SH 08 Agosto 2026 Giornaliero
ESSC · Strategy Shares 0,15% 712 NS 30 Aprile 2026 N-PORT
BIB · ProShares Trust 0,14% 1.439 NS 31 Maggio 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,09% 237.749 SH 08 Agosto 2026 Giornaliero
IWM · iShares Trust 0,08% 1.053.632 SH 08 Agosto 2026 Giornaliero
GSSC · Goldman Sachs ETF Trust 0,08% 11.051 NS 31 Maggio 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,08% 1.185 NS 30 Aprile 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 9.665 NS 30 Aprile 2026 N-PORT
ITWO · ProShares Trust 0,06% 1.654 NS 31 Maggio 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,06% 2.459 SH 08 Agosto 2026 Giornaliero
RSSL · Global X Funds 0,06% 15.208 NS 30 Aprile 2026 N-PORT
ESML · iShares Trust 0,05% 22.118 SH 08 Agosto 2026 Giornaliero
DFAS · Dimensional ETF Trust 0,05% 117.357 NS 30 Aprile 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,05% 143.168 NS 31 Maggio 2026 N-PORT
ISCG · iShares Trust 0,04% 6.428 SH 08 Agosto 2026 Giornaliero
VHT · VANGUARD WORLD FUND 0,04% 114.187 SH 08 Agosto 2026 Giornaliero
UWM · ProShares Trust 0,04% 1.294 NS 31 Maggio 2026 N-PORT
ISCB · iShares Trust 0,04% 1.688 SH 08 Agosto 2026 Giornaliero
ISCV · iShares Trust 0,04% 3.927 SH 08 Agosto 2026 Giornaliero
SMLF · iShares Trust 0,03% 20.757 SH 08 Agosto 2026 Giornaliero
FHLC · FIDELITY COVINGTON TRUST 0,03% 16.096 NS 30 Aprile 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,03% 374.291 SH 08 Agosto 2026 Giornaliero
URTY · ProShares Trust 0,03% 1.307 NS 31 Maggio 2026 N-PORT
WSML · iShares Trust 0,02% 2.078 SH 08 Agosto 2026 Giornaliero
DXUV · Dimensional ETF Trust 0,02% 1.178 NS 30 Aprile 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,01% 1.399 NS 31 Maggio 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,01% 23.351 NS 31 Maggio 2026 N-PORT
HDG · ProShares Trust 0,01% 33 NS 31 Maggio 2026 N-PORT
DCOR · Dimensional ETF Trust 0,01% 4.910 NS 30 Aprile 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0,01% 11.015 NS 31 Maggio 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 51.657 NS 30 Aprile 2026 N-PORT
IWV · iShares Trust 0,00% 11.704 SH 08 Agosto 2026 Giornaliero
IETC · iShares U.S. ETF Trust 0,00% 375 SH 08 Agosto 2026 Giornaliero
ACVF · ETF Opportunities Trust 0,00% 82 NS 30 Aprile 2026 N-PORT
ITOT · iShares Trust 0,00% 45.817 SH 08 Agosto 2026 Giornaliero
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 192 NS 31 Maggio 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 17.955 NS 31 Maggio 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 9.362 NS 30 Aprile 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 4.660 NS 30 Aprile 2026 N-PORT
DFUV · Dimensional ETF Trust 0,00% 3.550 NS 30 Aprile 2026 N-PORT
DFLV · Dimensional ETF Trust 0,00% 321 NS 30 Aprile 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 1.228.926 SH 08 Agosto 2026 Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3.407 SH 08 Agosto 2026 Giornaliero